A Phase III, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia.
Phase of Trial: Phase III
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 06 May 2010 Results presented at 29th Annual Scientific Meeting of the American Pain Society.
- 14 Apr 2010 Results presented at 62nd Annual Meeting of the American Academy of Neurology 2010.
- 16 Dec 2009 According to a Jazz Pharmaceuticals media release, a New Drug Application has been submitted to the US FDA based on results from this and another pivotal trial (trial profile 700020839).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History